FDA Indicates Flexibility On Evidence To Support Efficacy In Pneumonia
This article was originally published in The Pink Sheet Daily
Executive Summary
The agency will seek advisory panel input Nov. 3-4 on options for facilitating trials in community-, hospital- and ventilator-acquired pneumonia.